Top Markets
Coin of the day
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Peringkat dalam Saham #13779
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Harga Saham
$12.63
Kapitalisasi Pasar
$458.19M
Perubahan (1 hari)
-3.26%
Perubahan (1 tahun)
-
Negara
US
Perdagangan Evommune, Inc. (EVMN)

Kategori

Riwayat pemecahan saham untuk Evommune, Inc. (EVMN)
Saham Evommune, Inc. (simbol: EVMN) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 31, 2026.
Satu lembar saham EVMN yang dibeli sebelum Aug 31, 2026 sekarang setara dengan 0 lembar saham EVMN.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH